Society for Research on Nicotine and Tobacco
SRNT 2025 12 - 15 March 2025

Effect of Semaglutide on Smoking Cessation and Cardiovascular Outcomes by Smoking Status in Patients with Overweight or Obesity and Cardiovascular Disease - Results from the SELECT Trial

Authors :

Donna H. Ryan1; Helen M. Colhoun2; Scott S. Emerson3; Steven E. Kahn4; Robert F. Kushner5; A. Michael Lincoff6; Ildiko Lingvay7; Jorge Plutzky8; Selçuk Dağdelen9; Mikko Pietilä10; Pernille Auerbach11; Søren Rasmussen11; Ruben Duque do Vale11
Affiliations
View Details Hide Details
<p>SRNT2025_SELECT_Smoking_poster</p>
<p>SRNT2025_SELECT_Smoking_poster</p>
Keywords
Obesity
Cardiovascular Disease
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)